Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
Sunday, October 20, 2013 - 20:00
in Health & Medicine
An investigational drug has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene.